DOE’s new Funding Opportunity Announcement provides an opportunity to collaborate with the ABF. This $5 million program will focus on high priority R&D areas of interest within the biomanufacturing space, including advanced bioprocessing techniques (such as cell-free systems or continuous fermentation processes) and engineering of more efficient production hosts. For more information on the program and how to submit an application, please visit the DOE website here.
If your company is interested in exploring the opportunity to collaborate with the ABF, please submit your details via the contact form below, including a brief summary about what your proposed project is and the challenges you hope to overcome.
Collaborative Research and Development Agreements and Strategic Partnership Programs
Collaborative Research and Development Agreements (CRADAs) and Strategic Partnership Programs (SPPs) are mechanisms under which the ABF can work together with Industry.
SPPs tend to be smaller engagements and often involve the ABF performing a single unit operation (e.g., targeted proteomics analysis) for the Industrial Partner. SPPs may be very attractive to Industry, as the Industrial Partner retains all intellectual property (IP) rights derived from the work performed. CRADAs tend to be larger engagements involving the ABF performing multiple unit operations in collaboration with the Industrial Partner (which may embed its staff at ABF facilities while pursuing the scope of the project’s work).
Under CRADAs, IP ownership follows inventorship, with the Industrial Partner generally having an option to negotiate an exclusive license to ABF (co-)invented IP in specific field(s) of use. There may be certain other restrictions placed on CRADAs and SPPs, for example the scope of the project’s work must only include domain expertise and capabilities exclusively/uniquely available from the ABF national labs (i.e., are not otherwise commercially available), and developed processes/products that are derivative of the work performed may need to be first substantially implemented/manufactured in the United States.
The Agile Biofoundry CRADA will be used for all ABF projects, and if the project is receiving DOE-funding, this CRADA is non-negotiable. If the CRADA is funded entirely with non-DOE funds, changes will be considered. The CRADA is applicable only to ABF projects where there is one non-DOE lab party, although there may be any number of DOE labs.
Agile BioFoundry (ABF) Researchers are free to collaborate with other researchers from within academic/non-profit/government institutions, with the work either needing to be directly aligned with the ABF’s mission, or the collaborating parties required to secure additional sources of funding to pursue the collaborative work.